PubMed Health⌕ Search

PubMed · 14742407

Incomplete guidelines.

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tong J Gan, Tricia Meyer, Christian C Apfel, Frances Chung, Peter J Davis, Steve Eubanks, Anthony Kovac, Beverly Philip, Daniel I Sessler, James Temo, Martin R Tramèr, Mehernoor Watcha. 2004. Incomplete guidelines.. https://doi.org/10.1213/01.ane.0000077703.55641.ec

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Classification in nonspecific low back pain: what methods do primary care clinicians currently use?

STUDY DESIGN: Postal survey. OBJECTIVES: To describe the signs and symptoms that clinicians think represent nonspecific low back pain (NSLBP) subgroups, and to report the labels that clinicians give to those subgroups. SUMMARY OF BACKGROUND DATA: The cause of most low back pain (LBP) cannot be diagnosed. Consequently, approximately 80% of primary care LBP presentations are most accurately labeled as NSLBP. Most Australian primary care clinicians think that NSLBP is heterogeneous and treat patients differently based on that heterogeneity. This research sought to identify the subgroups clinicians believe are recognizable within that heterogeneity. METHODS: Analysis of survey data from 651 primary care clinicians from 6 professional disciplines: physiotherapy, manipulative physiotherapy, chiropractic, osteopathy, general medicine, and musculoskeletal medicine. RESULTS: There was little consensus among participating clinicians regarding the signs and symptoms that identify NSLBP subgroups. Most clinicians give labels to NSLBP subgroups that imply putative pathoanatomy, however, the evidence that these labels are valid is scant and controversial. CONCLUSIONS: A lack of consensus among participating clinicians regarding NSLBP subgroups and a lack of evidence for the validity of NSLBP subgrouping are a compelling argument for further research into this clinical practice.

Consensus↗

Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.

Treatment guidelines are considered to be an important tool in steering patients to medical treatment. This study was conducted to analyze guidelines for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDUs) in the European Union (EU) countries as a component of treatment access. National and international databases, expert contacts, professional societies, and health administrations were approached to acquire guidelines. According to their quality standard, guidelines were divided into expert opinions, semiofficial guidelines, official guidelines, and consensus processes. Recommendations for the treatment of HCV infection in IDUs vary substantially, from lack of recommendations and outright treatment disapproval to recommendations for treatment under specified circumstances. Recent guidelines that apply qualified process procedures that include literature research tend to be more permissive. Qualified guideline processes in each EU country and subsequently renewed pan-European guidelines are needed.

Consensus↗